Adjuvant Hormonal Treatment for Prostate Cancer: The Bicalutamide Early Prostate Cancer Program

Publisher： Karger

E-ISSN： 1423-0232|65|1|1-4

ISSN： 0030-2414

Source： Oncology, Vol.65, Iss.1, 2003-09, pp. : 1-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Perspectives in Adjuvant Treatment of Prostate Cancer

By  

Urologia Internationalis, Vol. 68, Iss. 1, 2002-01 ,pp. : 1-5

Karger

Access to resources Recommend Favorite

Early versus Deferred Hormonal Treatment for Asymptomatic Prostate Cancer

By  

Oncology Research and Treatment, Vol. 24, Iss. 3, 2001-07 ,pp. : 214-220

Karger

Access to resources Recommend Favorite

Neoadjuvant Hormonal Treatment and Radiotherapy for Prostate Cancer

By  

Oncology, Vol. 65, Iss. 1, 2003-09 ,pp. : 29-33

Karger

Access to resources Recommend Favorite

Hormonal Predictors of Prostate Cancer

By  

Urologia Internationalis, Vol. 79, Iss. 1, 2007-07 ,pp. : 13-18

Karger

Access to resources Recommend Favorite

Comparison of Gene Expression in LNCaP Prostate Cancer Cells after Treatment with Bicalutamide or 5-Alpha-Reductase Inhibitors

By  

Urologia Internationalis, Vol. 84, Iss. 2, 2010-03 ,pp. : 203-211

Karger

Access to resources Recommend Favorite